![]() |
市場調查報告書
商品編碼
2026840
外科敷料市場預測至2034年:按產品、應用、最終用戶和地區分類的全球分析Surgical Dressing Market Forecasts to 2034 - Global Analysis By Product, By Application, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球外科敷料市場預計到 2026 年將達到 63 億美元,並在預測期內以 7.6% 的複合年成長率成長,到 2034 年達到 114 億美元。
外科敷料是用於傷口和切口的無菌材料,旨在促進癒合和預防感染。它們由紗布、繃帶和膠帶等材料製成,能夠吸收滲出液,保護傷口免受污染,並維持適當的恢復環境。其益處包括降低感染風險、促進組織修復和提高舒適度。外科敷料在術後護理、創傷治療和傷口管理中至關重要。
根據美國整形外科醫師協會統計,2018 年美國約有 1,800 萬人接受了微創美容手術。
慢性病增多
隨著糖尿病和心血管疾病盛行率的不斷上升,對有效創傷護理和感染預防的需求日益成長。此外,人口老化導致關節重建和心血管手術等外科手術數量增加。手術敷料在術後護理中發揮著至關重要的作用,它能提供無菌屏障,最大限度地降低感染風險,並促進創傷治療。隨著全球醫療保健系統應對這些挑戰,對先進且高效的手術敷料解決方案的需求持續成長。
先進產品成本高昂
採用智慧材料、抗菌劑和先進創傷治療技術的高科技外科敷料通常價格昂貴。這給這些產品的廣泛應用帶來了挑戰,尤其對於預算緊張的醫療系統和注重成本的消費者而言更是如此。患者和醫療服務提供者面臨的經濟負擔限制了他們獲得這些先進解決方案的機會,導致他們選擇更具成本效益的替代方案。
提高對感染預防的認知
隨著醫療保健意識的提高,創傷護理中感染控制的重要性日益凸顯。這種意識的增強推動了對具有更強抗菌性能和更強抗感染能力的先進外科敷料的需求。消費者和醫療保健專業人員都在積極尋找不僅能促進創傷治療,還能最大限度地降低感染風險的產品。這一趨勢為市場新進業者提供了推出和推廣創新外科敷料解決方案的機會,創造了一個以預防感染為關鍵考慮的市場環境。同時,這也加速了抗菌技術的研發,並創造了一個能夠透過高效且方便用戶使用的產品來滿足不斷變化的醫療保健需求的市場環境。
供應鏈中斷
地緣政治緊張局勢、天災或全球疫情等因素可能擾亂供應鏈,導致外科敷料關鍵零件短缺。這些中斷不僅影響生產計劃,還會導致成本增加和物流挑戰。對全球供應鏈的依賴使市場容易受到製造商無法控制的外部因素的影響。為了降低這種威脅,產業相關人員必須投資於具有韌性的供應鏈管理策略,以實現採購多元化,並制定緊急時應對計畫對於確保原料的穩定供應和維持市場上外科敷料的持續供應至關重要,從而避免對患者照護和醫療基礎設施造成潛在的不利影響。
新冠疫情對外科敷料市場產生了重大影響,導致全球醫療機構對創傷護理產品的需求激增。與病毒相關的住院和手術激增,提高了對無菌敷料和先進創傷護理解決方案的需求。此外,疫情加速了遠端醫療的普及,影響了適用於遠距患者照護的外科敷料的研發。供應鏈中斷、醫療優先事項的轉變以及醫療系統面臨的壓力,進一步塑造了新冠疫情期間及之後外科敷料市場的趨勢。
在預測期內,二次敷料細分市場預計將是最大的。
預計輔助敷料市場將成為盈利豐厚的成長領域。這些敷料可為主要敷料提供額外的保護、滲出液吸收和支撐,從而確保最佳的創傷治療環境。輔助敷料常用於複雜傷口和固定主要敷料,其形式多種多樣,包括紗布、薄膜、泡棉和親水膠體敷料。它們有助於維持無菌環境、預防感染並提高患者舒適度。輔助敷料的多功能性和適應性使其成為綜合創傷護理方案的重要組成部分,能夠滿足不同患者的需求,並有助於改善整體治療效果。
在預測期內,醫院產業預計將呈現最高的複合年成長率。
在預測期內,醫院領域預計將呈現最高的複合年成長率。手術敷料對於醫院環境中的術後護理、傷口管理和感染預防至關重要。手術數量的不斷增加,以及對感染控制日益重視,正在推動對先進手術敷料解決方案的需求。醫院優先使用無菌且有效的敷料,以確保患者獲得最佳治療效果。此外,醫院與手術敷料製造商之間的持續合作,正推動創新產品的開發,以滿足不同醫療環境中醫護人員和病患的特定需求。
在預測期內,北美外科敷料市場預計將繼續保持顯著的市場佔有率,這主要得益於其完善的醫療保健基礎設施、先進的醫療技術以及需要手術干預的慢性疾病的高發生率。該地區擁有完善的法規結構,確保了外科敷料的品質和安全,從而增強了消費者的信心。此外,人口老化也推動了術後護理產品需求的成長。持續的技術創新、不斷提高的感染預防意識,以及對醫療保健的高度重視和良好的市場生態系統,都進一步促進了市場的發展。
預計亞太地區在預測期內將呈現最高的複合年成長率。人口成長、醫療保健支出增加以及人們對先進創傷護理解決方案的日益關注,都推動了市場擴張。在中國和印度等國家,外科手術數量的激增以及慢性病的高發生率,正在推動對外科敷料的需求。該地區的創傷護理產品技術創新也在不斷進步。隨著醫療基礎設施的完善和對患者療效的日益重視,亞太地區已成為外科敷料製造商的重要市場,為企業提供了成長和市場滲透的機會。
According to Stratistics MRC, the Global Surgical Dressing Market is accounted for $6.3 billion in 2026 and is expected to reach $11.4 billion by 2034 growing at a CAGR of 7.6% during the forecast period. Surgical dressing refers to sterile materials applied to wounds or incisions to promote healing and prevent infection. Comprising gauze, bandages, and adhesive strips, it serves to absorb exudates, protect the wound from contaminants, and maintain a conducive environment for recovery. Advantages include minimizing infection risks, supporting tissue repair, and providing comfort. Surgical dressings are crucial in postoperative care, injury treatment, and wound management.
According to the American Society of Plastic Surgeons, approximately 18 million people in the U.S. underwent minimally invasive cosmetic surgical procedures in 2018.
Rising incidence of chronic diseases
With an increasing incidence of conditions like diabetes and cardiovascular diseases, there's a heightened need for effective wound care and infection prevention. Additionally, the growing aging population contributes to a higher number of surgeries, such as joint replacements and cardiac procedures. Surgical dressings play a pivotal role in postoperative care by providing a sterile barrier, minimizing infection risks, and promoting optimal wound healing. As healthcare systems globally address these challenges, the demand for advanced and efficient surgical dressing solutions continues to rise.
High cost of advanced products
Technologically advanced surgical dressings incorporating smart materials, antimicrobial agents, and sophisticated wound-healing technologies often come with a higher price tag. This poses a challenge to widespread adoption, particularly in healthcare systems with budget constraints and cost-conscious consumers. The economic burden on patients and healthcare providers limits the accessibility of these advanced solutions, hindering their adoption in favor of more cost-effective alternatives.
Growing awareness of infection prevention
As healthcare awareness grows, there is a heightened emphasis on the importance of infection control in wound care. This awareness is driving demand for advanced surgical dressings with enhanced antimicrobial properties and infection-resistant features. Consumers and healthcare providers are actively seeking products that not only facilitate wound healing but also minimize the risk of infections. This trend opens doors for market players to introduce and promote innovative surgical dressing solutions, fostering a market environment where infection prevention is a key consideration. It also encourages the development of antimicrobial technologies, positioning the market to address evolving healthcare needs with effective and awareness-driven products.
Supply chain disruptions
Factors such as geopolitical tensions, natural disasters, or global pandemics can disrupt the supply chain, leading to shortages of critical components for surgical dressings. These disruptions not only affect production timelines but also contribute to increased costs and logistical challenges. The dependence on a global supply chain makes the market vulnerable to external factors beyond the control of manufacturers. To mitigate this threat, industry players must invest in resilient supply chain management strategies, diversify sourcing options, and establish contingency plans. Proactive measures are essential to ensure a stable supply of materials and maintain the uninterrupted availability of surgical dressings in the market, safeguarding against potential adverse impacts on patient care and healthcare infrastructure.
The Covid-19 pandemic has significantly impacted the Surgical Dressing Market, leading to increased demand for wound care products in healthcare facilities globally. With a surge in hospitalizations and surgeries related to the virus, there has been a heightened need for sterile dressings and advanced wound care solutions. Additionally, the pandemic has accelerated the adoption of telemedicine, influencing the development of surgical dressings suitable for remote patient care. Supply chain disruptions, fluctuating healthcare priorities, and the strain on healthcare systems have further shaped the dynamics of the surgical dressing market during and post-Covid-19.
The secondary dressing segment is expected to be the largest during the forecast period
The secondary dressing segment is expected to have a lucrative growth. These dressings provide added protection, absorption of exudate, and support to the primary dressing, ensuring optimal wound healing conditions. Commonly used in complex wounds or to secure primary dressings, secondary dressings come in various forms, such as gauze, films, foams, or hydrocolloids. They contribute to maintaining a sterile environment, preventing infections, and promoting patient comfort. The versatility and adaptability of secondary dressings make them integral in comprehensive wound care protocols, catering to diverse patient needs and contributing to overall positive treatment outcomes.
The hospitals segment is expected to have the highest CAGR during the forecast period
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period. Surgical dressings are integral in postoperative care, wound management, and infection prevention within hospital settings. The rising number of surgeries, coupled with a growing emphasis on infection control, propels the demand for advanced surgical dressing solutions. Hospitals prioritize the use of sterile and effective dressings to ensure optimal patient outcomes. Moreover, ongoing collaborations between hospitals and surgical dressing manufacturers contribute to the development of innovative products, addressing the specific needs of healthcare professionals and patients in diverse medical scenarios.
During the forecast period, it is expected that the North American Surgical Dressing market will continue to hold a majority of the market share driven by a robust healthcare infrastructure, advanced medical technologies, and a high prevalence of chronic diseases requiring surgical interventions. The region's well-established regulatory framework ensures the quality and safety of surgical dressings, fostering trust among consumers. Additionally, a growing aging population contributes to an increased demand for postoperative care products. Ongoing technological innovations and the rising awareness of infection prevention further propel the market with a strong focus on healthcare and a supportive market ecosystem.
Asia Pacific is projected to have the highest CAGR over the forecast period. The growing population, increasing healthcare expenditures, and rising awareness about advanced wound care solutions contribute to the market's expansion. In countries like China and India, a surge in surgical procedures, coupled with a higher prevalence of chronic diseases, fuels the demand for surgical dressings. The region also witnesses ongoing technological innovations in wound care products. With improving healthcare infrastructure and a focus on patient outcomes, Asia Pacific represents a key market for surgical dressing manufacturers, presenting opportunities for growth and market penetration.
Key players in the market
Some of the key players in Surgical Dressing market include 3M Company, B. Braun SE, Baxter, Smith and Nephew plc., Cardinal Health Inc., Organogenesis Holdings Inc., Coloplast Corp, Molnlycke Health Care AB, Convatec Group PLC, Derma Sciences Inc. (Integra LifeSciences), Essity Aktiebolag AB, Johnson & Johnson Private Limited and Medtronic.
In August 2023, TE Connectivity announced the launch of its new line of hybrid fiber optic connectors.
In April 2023, the FDA clearance for 3M Health Care's 3M Veraflo Therapy, including 3M V.A.C. Veraflo Cleanse Choice Dressing, and 3M Veraflo Cleanse Choice Complete Dressing expanded the company's customer base and increased its revenue. This innovative approach for wound care offered improved treatment options, making it more attractive to healthcare providers and potentially boosting the company's financial performance.
In January 2023, Convatec announced the U.S. launch of ConvaFoam, a family of advanced foam dressings that can be used on a spectrum of wound types at any stage for wound management and skin protection.
In June 2022, Collagen Matrix received 510(k) clearance for a new fibrillar collagen wound dressing. The collagen matrix fibrillar collagen wound dressing is an absorbent microfibrillar matrix used to treat wounds that moderately to extensively exude fluid as well as control mild bleeding.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.